Eosinophilic Esophagitis (EoE) Clinical Trial
Official title:
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
A study in adolescents and adults with eosinophilic esophagitis (EoE) to measure the histologic response and determine if any reduction in dysphagia is achieved.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04394351 -
Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
|
Phase 3 | |
Terminated |
NCT03245840 -
Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)
|
Phase 3 | |
Completed |
NCT03581838 -
Eating With Eosinophilic Esophagitis (EoE)
|
||
Completed |
NCT02778867 -
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
|
Phase 2/Phase 3 | |
Completed |
NCT01642212 -
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
|
Phase 2 | |
Completed |
NCT05485779 -
SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04626609 -
Prostaglandin and Cannabinoid Receptors in EoE
|
||
Completed |
NCT00762073 -
Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis
|
Phase 2 | |
Terminated |
NCT02058537 -
Bethanechol for Eosinophilic Esophagitis
|
Phase 2 | |
Completed |
NCT02320981 -
Mucosal Impedance in Pediatric Population
|
N/A | |
Recruiting |
NCT06389994 -
Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
|
||
Completed |
NCT02736409 -
An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)
|
Phase 3 |